Objectives: Pediatric cardiac ICUs should be adept at treating both critical medical and surgical conditions for patients with cardiac disease. There are no case-mix adjusted quality metrics specific to medical cardiac ICU admissions. We aimed to measure case-mix adjusted cardiac ICU medical mortality rates and assess variation across cardiac ICUs in the Pediatric Cardiac Critical Care Consortium. Design: Observational analysis. Setting: Pediatric Cardiac Critical Care Consortium clinical registry. Patients: All cardiac ICU admissions that did not include cardiac surgery. Interventions: None. Measurements and Main Results: The primary endpoint was cardiac ICU mortality. Based on multivariable logistic regression accounting for clustering, we created a case-mix adjusted model using variables present at cardiac ICU admission. Bootstrap resampling (1,000 samples) was used for model validation. We calculated a standardized mortality ratio for each cardiac ICU based on observed-to-expected mortality from the fitted model. A cardiac ICU was considered a statistically significant outlier if the 95% CI around the standardized mortality ratio did not cross 1. Of 11,042 consecutive medical admissions from 25 cardiac ICUs (August 2014 to May 2017), the observed mortality rate was 4.3% (n = 479). Final model covariates included age, underweight, prior surgery, time of and reason for cardiac ICU admission, highrisk medical diagnosis or comorbidity, mechanical ventilation or extracorporeal membrane oxygenation at admission, and pupillary reflex. The C-statistic for the validated model was 0.87, and it was well calibrated. Expected mortality ranged from 2.6% to 8.3%, reflecting important case-mix variation. Standardized mortality ratios ranged from 0.5 to 1.7 across cardiac ICUs. Three cardiac ICUs were outliers; two had lower-than-expected (standardized mortality ratio <1) and one had higher-than-expected (standardized mortality ratio >1) mortality. Conclusions: We measured case-mix adjusted mortality for cardiac ICU patients with critical medical conditions, and provide the first report of variation in this quality metric within this patient population across Pediatric Cardiac Critical Care Consortium cardiac ICUs. This metric will be used by Pediatric Cardiac Critical Care Consortium cardiac ICUs to assess and improve outcomes by identifying high-performing (low-mortality) centers and engaging in collaborative learning. (Pediatr Crit Care Med 2019; 20:143-148) 
P ediatric cardiac ICUs (CICUs) initially evolved from general PICUs into specialized critical care units to provide postoperative care for children undergoing increasingly complex cardiac surgical interventions. Those admissions that do not include cardiac surgery-medical admissionsresult from a diverse set of indications for critical care: routine post-procedural care (e.g., catheterizations or noncardiac surgery), evaluation of structural heart disease, and for treatment of acute medical conditions in surgical patients who develop complications while convalescing on the non-ICU ward, patients with decompensated heart failure, and patients with primary heart disease who present with general critical illness, among others. Caring for medical patients is inherently different from providing postoperative care, and CICU quality may differ across these admission types. Focused assessment of quality of care in medical admissions can offer important insights to hospitals looking to improve outcomes for children with critical cardiovascular disease.
However, CICU quality metrics and case-mix adjustment methods specific to medical admissions have not been developed to date. Previous efforts to study CICU quality have focused on postoperative admissions (1) . Analyses to derive case-mix adjustment models have been applied to general PICU populations, in some cases inclusive of cardiovascular medical admissions, but none of these analyses have been adequately tested within pediatric CICUs (2, 3) . Existing evidence suggests that these previous models do not perform well for patients with critical cardiovascular disease (4, 5) , and some predictor variables (e.g., Pao 2 ) lack face validity for the heterogeneous physiologies seen in a CICU, necessitating new approaches tailored to this clinical setting. As such, it remains unknown whether the quality of care for medical patients varies across CICUs. This uncertainty hinders attempts to uncover key drivers of performance and initiate potential quality improvement initiatives.
In this context, we sought to measure CICU quality of care in medical admissions using adjusted mortality as the outcome metric and to describe variation in adjusted mortality across the CICUs participating in the Pediatric Cardiac Critical Care Consortium (PC 4 ). To do so, we created a CICU-specific casemix adjustment model from the PC 4 registry. We hypothesized 1) that important variation in the characteristics of medical admissions exists across CICUs, underscoring the need for a validated case-mix adjusted model and 2) that we could identify outlying CICUs with statistically significant higher-than or lower-than-expected mortality.
METHODS

Data Source
PC
4 is a quality improvement collaborative that collects data on all patients with primary cardiac disease admitted to the CICU attending service at participating hospitals (6) . PC 4 maintains a clinical registry to support research and quality improvement initiatives. Each participating center has a trained data manager who has completed a certification examination. The data managers collect and enter data in accordance with the standardized PC 4 Data Definitions Manual. The PC 4 registry shares common terminology and definitions with applicable data points from the International Pediatric and Congenital Cardiac Code, Society of Thoracic Surgeons Congenital Heart Surgery Database, and American College of Cardiology Improving Pediatric and Adult Congenital Treatment Registry, as previously described (6) . Participating centers are audited on a regular schedule, and audit results suggest complete, accurate and timely submission of data across centers, with the published results demonstrating a major discrepancy rate of 0.6% across 29,476 fields (7). The University of Michigan Institutional Review Board provides oversight for the PC 4 Data Coordinating Center; this study was reviewed and approved with waiver of informed consent.
Inclusion and Exclusion Criteria
The study period spanned from August 1, 2014, to May 31, 2017; the start date corresponds to the current version of the PC 4 registry when specific variables were added for the purpose of performing this analysis. Twenty-five CICUs contributed at least one medical admission to the registry over this period.
CICU admissions were included if no cardiac surgery occurred either immediately prior to (e.g., patient not admitted directly from the cardiac operating room or postanesthesia unit) or during the CICU admission; this defines a medical CICU admission in the registry. Each CICU admission ends with discharge or transfer from the CICU. Repeat CICU admissions (~1%) were eligible for analysis and were treated as independent events in the analysis. Although this statistical assumption is a potential source of bias, these admissions are infrequent, and they are high risk so were deemed clinically important to include. Exclusion criteria included admission for hospice care and/or admissions where a patient had a do not resuscitate order on arrival to the CICU (n = 54), and PICU overflow admissions (patients without cardiovascular disease, n = 172). One site had submitted only two medical admissions to the registry at the time of analysis and was dropped from comparative analyses.
Outcome and Predictor Variables
CICU mortality was the primary outcome. We assessed candidate predictors of mortality including patient characteristics (e.g., age, noncardiac comorbidities), admission characteristics (e.g., source of admission, time of day, reason for admission), acute conditions present on arrival, and a set of variables related to illness severity captured specifically in the registry for evaluation in this model that included laboratory values and cardiac-specific disease modifiers (Appendix 1, Supplemental Digital Content 1, http://links.lww.com/PCC/A779). The candidate predictors were selected by consensus and were considered independent of CICU quality of care by the study investigators.
We characterized high-mortality admission diagnoses based on empirical associations with mortality. Briefly, each CICU admission for acute medical condition has one Pediatric Critical Care Medicine www.pccmjournal.org 145 medical diagnosis assigned. We assessed mortality rates for each diagnosis and characterized those in the top quartile as high risk. Our method classifying each patient as high risk or low risk based on the combination of diagnoses and cardiovascular specific comorbidities is described in detail in Appendix 2 (Supplemental Digital Content 1, http://links. lww.com/PCC/A779).
We analyzed acute conditions present at or shortly after CICU admission as potential predictors of mortality. We assessed these variables relative to the CICU time of admission at four separate points (Appendix 1, Supplemental Digital Content 1, http://links.lww.com/PCC/A779): present in a previous encounter during the hospitalization, present on arrival to CICU, present on arrival or less than 1 hour after CICU admission, and present on arrival or less than 2 hours after CICU admission. There was a high degree of collinearity between these variables, and most were significantly associated with mortality. We operated under a conceptual model that events occurring within the first hour of admission were not related to CICU quality of care, but likely reflected the patients' severity of illness at the time of arrival. Therefore, we selected acute conditions present on arrival or within the first hour after CICU admission as covariates in the case-mix adjustment model and ignored the other time points. We did include those conditions present in previous encounters if they were significantly associated with mortality on univariate analysis, but the present on arrival variable was not.
Statistical Analysis
Our analysis was designed to measure CICU quality of care using mortality as the metric while adjusting for case-mix differences across CICUs. We first created a case-mix adjusted model (PC 4 CICU Medical Mortality Model) to account for differences across hospitals' inpatient characteristics and illness severity on arrival to the CICU. This model was used to predict mortality at the population level; it was not intended for predicting mortality in individual patients.
We evaluated all candidate predictor variables in univariate analyses using chi-square test, Fisher exact test, or Wilcoxon rank-sum test as appropriate. Variables associated with mortality at p value of less than 0.1 in the univariate analyses were included in a multivariable logistic regression model. We used a hierarchical (multilevel) model with a hospital-specific random effect to account for clustering of patients within hospitals. Additionally, a hospital level covariate included in the analysis was whether or not ventricular assist device and/or heart transplant are offered by the institution. Our rationale for this variable was that hospitals that do not offer advanced heart failure therapies may have lower mortality rates as a result of transferring out this high-mortality population; five hospitals in the cohort do not offer these advanced heart failure therapies. We used the variance inflation factor test to assess multicollinearity, which showed no significant collinearity among variables included in the model. We then performed bootstrapping (using 1,000 resamples) to obtain bias-corrected 95% CIs of the odds ratio for each covariate in the final model.
All covariates whose CI did not cross 1 were included in the final model.
Laboratory values-serum creatinine, lactate, and betanatriuretic peptide-were recorded if they were drawn within 2 hours before or after admission. Inclusion of laboratory values was complicated by a high rate of missing data; no laboratory variable was collected on greater than 50% of the admissions and less than 25% had all three laboratory collected. We assessed the laboratory value variables continuously and categorically and included a category for "not obtained." We imputed the missing laboratory values for every admission based on other covariates and included these in subsequent multivariable models for predicting mortality. However, inclusion of the imputed laboratory variables negatively affected stability of the significant predictors of mortality in the final model, with no improvement in model performance. On the basis of these empirical findings, we elected to exclude the laboratory variables from the final case-mix adjusted model.
From the bootstrapping, we calculated an optimism-corrected C-statistic for the final model. We assessed calibration of the final model using the Hosmer-Lemeshow chi-square test (p > 0.05 demonstrating adequate fit of the model). Goodnessof-fit was also assessed qualitatively across 10 groups rankordered by predicted probability of mortality. Maximum Vasoactive-Inotropic Score (VIS) (8, 9) in the first 2 hours after admission was associated with mortality in the final model. However, the investigative team decided that this variable was susceptible to differences in CICU practice patterns. Therefore, we compared results from models with and without VIS and found the results to be similar. VIS was subsequently dropped from the final model.
We then used the final model to calculate a standardized mortality ratio (SMR) for each hospital. The SMR is calculated as the observed CICU medical mortality divided by the expected CICU medical mortality; expected mortality was derived from our final case-mix adjusted model. From our original bootstrapping, we obtained bias-corrected 95% CIs around the SMR estimate for each CICU. CICUs whose CIs did not cross 1 were considered to demonstrate statistically significant lower-than-expected (SMR < 1) or higher-thanexpected (SMR > 1) mortality. Analyses were performed using SAS Version 9.4 (SAS Institute, Cary, NC) or STATA Version 14 (Stata Corp, College Station, TX), with statistical significance at a p value of less than 0.05.
RESULTS
The final study cohort included 11,042 CICU medical admissions; this represents 37% of all admissions in the registry (pc4quality.org; accessed March 10, 2018). CICUs contributed between two and 1,139 (median, 401; interquartile range, 301-576). Overall unadjusted mortality was 4.3% (n = 479). Observed mortality ranged from 2.0% to 7.5% among the 24 CICUs in comparative analyses.
Selected patient and admission characteristics are shown in Supplemental links.lww.com/PCC/A780), as are the univariate associations with mortality. Patients with structural heart disease accounted for 70% of admissions. The most common reasons for admission were acute medical condition (72%) and postcardiac catheterization (14%). Only 9% had cardiac surgery during the same hospitalization, and 16% of admissions were readmissions to the CICU.
PC 4 CICU Medical Mortality Model
Results of the multivariable analysis to identify predictors of mortality are shown in Table 1 . Younger age, extracorporeal membrane oxygenation (ECMO), or cardiac arrest within 1 hour of CICU admission, dialysis, previous diagnosis of sepsis during the hospitalization, and high-risk diagnosis as reason for admission were the strongest predictors of increased mortality. Routine post-procedural care after noncardiothoracic surgery or catheterization was strongly associated with decreased odds of mortality. The final case-mix adjusted model (PC 4 CICU Medical Mortality Model) includes the variables in Table 1 . The optimism-corrected C-statistic was 0.87, and the Hosmer-Lemeshow chi-square statistic was 28.4 (p = 0.21) demonstrating excellent discrimination and calibration. The corresponding goodness-of-fit plot is shown in Online Supplemental Figure 1 (Supplemental Digital Content 3, http://links.lww.com/PCC/A781). The model predicted mortality accurately for both low-and high-risk admissions.
Assessing Variation in CICU Quality of Care
We used the PC 4 CICU Medical Mortality Model to calculate a SMR for 24 CICUs in the cohort. Expected mortality from the model ranged from 2.6% to 8.3%, reflecting important casemix differences across these CICUs. The SMR varied from 0.5 to 1.7 (Fig. 1) . Two CICUs had lower-than-expected mortality (CICUs 3 and 4; SMRs 0.6 and 0.8, respectively) and one was higher-than-expected (CICU 24, SMR 1.7). Figure 2 shows the expected mortality for each CICU arranged from lowest SMR to highest. There was no relationship between SMR and expected mortality (linear correlation coefficient, R 2 = 0.05), suggesting that the model provides a measure of adjusted mortality that is independent of the underlying case mix.
DISCUSSION
This is the first report demonstrating variation in adjusted mortality across pediatric CICUs related to patients admitted for medical conditions, which may represent differences in quality of care. We observed that some CICUs have important outlying standardized mortality rates in this patient population. Developing case-mix adjusted quality metrics for CICU medical admissions may stimulate quality improvement initiatives for this growing patient population. Our analysis revealed significant case-mix variation across CICUs; expected mortality varied almost four-fold across the CICUs in PC 4 . These data imply that hospitals differentially use their cardiac critical care beds, and indirectly may reflect differences in resources available in non-ICU settings. The observed variation in expected mortality (i.e., case mix) underscores the importance of developing and applying a clinically valid casemix adjustment model for pediatric CICUs, as we did in this analysis. Although not intended or statistically structured to directly compare the performance of two or more CICUs, this model allows each CICU to assess its quality of care relative to what is expected for its case mix. Given the differences in case mix across hospitals, observed outcomes alone would be misleading as a quality indicator for many CICUs. Previous risk adjustment methods have included cardiac medical patients in the derivation and validation cohorts (2, 3), but none of these have been evaluated specifically within this population. Informed by this previous work, we included some of the well-known predictors of mortality and extended it by adding granular information on cardiac diagnoses, surgical palliation status, and other markers of illness severity known to impact outcomes in this population.
We identified three of 24 CICUs whose mortality was not as expected, rather they had outlying performance (higheror lower-thanexpected). It is important to note that some CICUs had relatively small sample sizes (< 200 medical admissions) during the study period. This may in part be due to differences in CICU capacity and surgical volume, but also because each hospital began submitting data to the clinical registry at different time points. It is possible that additional hospitals may be identified as statistical outliers as more cases accrue. Identification of these outliers is crucial to quality improvement activities. PC 4 has developed a transparent reporting platform where CICUs can identify peers in the Consortium who achieve better-than-expected performance across a variety of quality metrics. The metric of adjusted CICU medical mortality has been implemented onto this reporting platform, and as such CICUs looking to improve their care to patients admitted for medical indications can access the knowledge and experience at these high performing sites. Further investigation may identify characteristics specific to high performing CICUs and improve the care of patients with medical cardiovascular disease.
Our focus on the medical subpopulation was driven by our interest in providing CICUs with tools to assess and improve quality. Examining overall mortality may not provide the requisite insight to improve because performance could differ within a CICU between surgical and medical populations. It is possible that systems factors and practices associated with performance in surgical admissions do not impact the care of medical patients, and vice versa. Our approach to case-mix adjustment can be applied to quality measurement for other outcomes in the medical CICU population such as acquired complication rates, failure-to-rescue (10), and CICU length of stay, which should allow CICUs to evaluate their performance across a wide array of quality metrics. Coupled with models developed specifically for postoperative admissions (11), CICUs will be able to identify areas of strength and weakness within these discrete patient populations and identify the specific resources necessary to improve care. Future work will examine differences in CICU outcomes across surgical and medical patients, and what structure and process factors may relate to differential performance.
There are potential limitations to our analysis. First, we chose to evaluate predictors of mortality up to the first hour after CICU admission. Although we believe that events in that time period like cardiac arrest and ECMO cannulation are more likely related to patient illness severity than CICU quality, in some instances this may not be true. This approach was endorsed by consensus among a multiinstitutional group of CICU clinician-scientists from PC 4 and has been accepted by the greater community within the Consortium. Second, we did not analyze a full complement of CICU and hospital characteristics associated with SMR to identify whether certain organizational, system, or practice variables may associate with quality. This is certainly an area of intense interest and will be assessed in follow-up analyses. Third, because of the way medical and surgical admissions are defined in the registry, some patients, particularly those with heart failure, present with an acute medical condition and then have surgery. These patients are not included in medical population outcome assessments such as this analysis, but they do require treatment of acute medical conditions. Fourth, mortality as an outcome does not account for varying institutional philosophies regarding withdrawal of life-sustaining therapies and the balance between functional survival and death when measuring quality. Finally, this analysis was conducted among large, dedicated pediatric CICUs from North America, so it remains unclear how the results would generalize to other care settings.
CONCLUSIONS
We demonstrated variation in adjusted mortality for medical admissions across a group of 24 pediatric CICUs. We must identify other domains where CICU quality of care varies in this patient population and determine whether important features of high performing CICUs can be disseminated to other institutions. The findings from this analysis have already been implemented into a tool that allows CICUs in PC 4 to monitor their outcomes and engage in collaborative learning with peers at CICUs who excel in the care of medical patients. Future work will focus on quality improvement that stems from this process.
